Once registered, you can:

  • - Read additional free articles each month
  • - Comment on articles and featured creative work
  • - Get our curated newsletters delivered to your inbox

By registering you agree to our privacy policy, terms & conditions and to receive occasional emails from Ad Age. You may unsubscribe at any time.

Are you a print subscriber? Activate your account.

$10 mil Zicam biz goes to Kovel/Fuller

Published on .

Gel Tech has tapped Kovel/Fuller, Los Angeles, for its $10 million account for Zicam, a preventative common cold nasal spray. Other competitors in the review included Ground Zero, Marina del Rey, and WongDoody and Colby Effler & Partners, both Santa Monica.

Copyright June 1999, Crain Communications Inc.

Most Popular
In this article: